VentriPoint Diagnostics (VPT.V) Buy, Sell or…

VentriPoint Diagnostics (VPT.V)

0.12

-0.01 (4.17%)

as of Jun 12, 2026, 5:03:04 pm Market Open.

26 watching

RISKY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The company develops and commercializes diagnostic tools to monitor heart disease. Minimal to no revenues so still very speculative. Largely in the development phase. They signed new contracts with GE Healthcare Corp and new patents are being filed. Unlock Premium - Try 5i Free

BUY

Takes a 2D ultrasound image and converts it to a 3D image that can be observed by surgeons. GE has a large number of ultrasound machines in the marketplace. Has asked them to adapt VentriPoint's system to their machines. China is also interested in adding their tech to their hospitals.

BUY

Takes 2D ultrasound images and coverts them to 3D, especially of the heart. MRI quality without the expense. In partnership with GE. Strong potential for a buyout. In the meantime, customers can buy this cost-saving, lifesaving technology today.

BUY

They take 2D images of the heart and convert to 3D. It's an alternative to an MRI, which is hard to access now. They may be wildly successful in China where they are testing their procedure. If China grants approval, then the opportunity here would be breathtaking.

Showing 1 to 4 of 4 entries

VentriPoint Diagnostics (VPT.V) Frequently Asked Questions

What is VentriPoint Diagnostics stock symbol?

VentriPoint Diagnostics is a Canadian stock, trading under the symbol VPT.V (previously VPT-X on Stockchase) on the TSX Venture Exchange (VPT-CV). It is usually referred to as TSXV:VPT or VPT.V

Is VentriPoint Diagnostics a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on VPT.V (previously VPT-X on Stockchase) on Stockchase. Read the latest expert commentary for VentriPoint Diagnostics .

Is VentriPoint Diagnostics a good investment or a top pick?

VentriPoint Diagnostics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for VentriPoint Diagnostics .

Why is VentriPoint Diagnostics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for VentriPoint Diagnostics .

Is VentriPoint Diagnostics worth watching?

VentriPoint Diagnostics is followed by 26 investors on Stockchase and is a trending stock that is worth watching.

What is VentriPoint Diagnostics stock price?

On 2026-06-12, VentriPoint Diagnostics (VPT.V) stock closed at a price of $0.12.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

VentriPoint Diagnostics (VPT.V)